Intelligent Medicine Acquisition Corp. Unit
IQMDU
IQMDU was delisted on the 26th of April, 2023.
64 hedge funds and large institutions have $123M invested in Intelligent Medicine Acquisition Corp. Unit in 2021 Q4 according to their latest regulatory filings, with 64 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Calamos Advisors
Naperville,
Illinois
|
+$12.7M |
| 2 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
+$10.1M |
| 3 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
+$8.11M |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$7.13M |
| 5 |
LA
Linden Advisors
New York
|
+$7.1M |
Top Sellers
IQMDU Hedge Fund Activity: Q4 2021 in Review
64 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Unit (IQMDU) for Q4 2021, worth a combined $123M.
Buyers outnumbered sellers: 64 funds opened new IQMDU positions and 0 closed out — a net gain of 64 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Calamos Advisors, opening a new position worth an estimated $12.7M.
- 64 institutional investors held Intelligent Medicine Acquisition Corp. Unit (IQMDU) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $123M of Intelligent Medicine Acquisition Corp. Unit stock for Q4 2021.
- 64 funds opened new Intelligent Medicine Acquisition Corp. Unit positions in Q4 2021 and 0 closed out, a net change of +64 holders.
- The largest Intelligent Medicine Acquisition Corp. Unit buyer in Q4 2021 was Calamos Advisors, an estimated $12.7M added.
Based on aggregated 13F filings for Q4 2021.